The effect of rectal heterogeneity on wall dose in high dose rate brachytherapy

Medical Physics

Volumn 36, Issue 1, 2009, Pages 224-232

  Kwan, I S ^a   Wilkinson, D ^a   Cutajar, D ^a   Lerch, M ^a   Rosenfeld, A ^a   Howie, A ^b   Bucci, J ^b   Chin, Y ^b   Perevertaylo, V L ^c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c SPA BIT ^*  (Ukraine)

Author keywords

High dose rate (HDR) brachytherapy; MOSFET detector; Prostate cancer; Rectum

Indexed keywords

DISEASES; LIGHT WEIGHT ROLLING STOCK; MONTE CARLO METHODS; RADIATION DECONTAMINATION; RADIOTHERAPY; UROLOGY;

HIGH-DOSE-RATE BRACHYTHERAPY; HOMOGENEOUS MEDIUM; MOSFET DETECTORS; POST TREATMENT; PROSTATE CANCERS; RECTUM; TREATMENT PLANNING SYSTEMS; WATER EQUIVALENT;

ONCOLOGY;

IRIDIUM 192;

ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DOSIMETER; DOSIMETRY; MONTE CARLO METHOD; PHANTOM; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECTUM; VALIDATION PROCESS;

EID: 58149115070     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3031111     Document Type: Article

References (46)

1. W. R. Lee, " Permanent prostate brachytherapy: The significance of postimplant dosimetry.," Rev. Urolo. 6 (4), S49-S56 (2004).
2. J. D. Cox, J. Stetz, and T. F. Pajak, " Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).," Int. J. Radiat. Oncol., Biol., Phys. 31 (5), 1341-1346 (1995).
3. T. Akimoto, " Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: Impact of rectal dose in high-dose-rate brachytherapy on occurrence of Grade 2 or worse rectal bleeding.," Int. J. Radiat. Oncol., Biol., Phys. 65 (2), 364-370 (2006).
4. G. M. Duchesne and L. J. Peters," What is the αΒ ratio for prostate cancer? Rationale for hypofractionated HDR brachytherapy.," Int. J. Radiat. Oncol., Biol., Phys. 44 (4), 747-748 (1999).
5. A. A. Martinez, " Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report.," Int. J. Radiat. Oncol., Biol., Phys. 49 (1), 61-69 (2001).
6. Y. Yoshioka, " High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a Phase I/II clinical trial.," Int. J. Radiat. Oncol., Biol., Phys. 48 (3), 675-681 (2000).
7. T. Akimoto, " Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: Impact of rectal dose in high-dose-rate brachytherapy on occurrence of Grade 2 or worse rectal bleeding.," Int. J. Radiat. Oncol., Biol., Phys. 65 (2), 364-370 (2006).
8. M. Butson, A. Rosenfeld, J. Mathur, M. Carolan, T. Wong, and P. Metcalfe, " A new radiotherapy surface dose detector: The MOSFET.," Med. Phys. 23 (5), 655-658 (1996).
9. T. Kron, M. Butson, F. Hunt, and J. Denham, " TLD extrapolation for skin dose determination in vivo.," Radiother. Oncol. 41, 119-123 (1996).
10. B. Nilsson and B. Sorcini, " Surface dose measurements in clinical photon beams.," Acta Oncol. 28 (4), 537-542 (1989).
11. J. Lambert, " In vivo dosimeters for HDR brachytherapy: A comparison of a diamond detector, MOSFET, TLD, and scintillation detector.," Med. Phys. 34 (5), 1759-1765 (2007).
12. S. Stathakis, " Ultra-thin TLDs for skin dose determination in high energy photon beams.," Phys. Med. Biol. 51, 3549-3567 (2006).
13. S. Devic, " Accurate skin dose measurements using radiochromic film in clinical applications.," Med. Phys. 33 (4), 1116-1124 (2006).
14. B. Gerbi, " The response characteristics of a newly designed parallel-plate ionization chamber in high-energy photon and electron beams.," Med. Phys. 20 (5), 1411 (1993).
15. I. S. Kwan, " Skin dosimetry with new MOSFET dosimeters.," Radiat. Meas. 43 (2-6), 929-932 (2008).
16. L. Archambault, " Plastic scintillation dosimetry: Optimal selection of scintillating fibers and scintillators.," Med. Phys. 32 (7), 2271-2278 (2005).
17. T. Kron, A. Elliot, and P. Metcalfe, " The penumbra of a 6 MV x-ray beam as measured by thermoluminescent dosimetry and evaluated using an inverse square root function.," Med. Phys. 20 (5), 1429-1438 (1993).
18. A. Rink, I. A. Vitkin, and D. A. Jaffray, " Characterization and real-time optical measurements of the ionizing radiation dose response for a new radiochromic medium.," Med. Phys. 32 (8), 2510-2516 (2005).
19. A. B. Rosenfeld, " MOSFET dosimetry on modern radiation oncology modalities.," Radiat. Prot. Dosim. 101 (1-4), 393-398 (2002).
20. ICRP (International Commission on Radiological Protection), " The biological basis for dose limitation in the skin.," ICRP Publication 59 (1991).
21. P. Scalchi, P. Francescon, and P. Rajaguru, " Characterization of a new MOSFET detector configuration for in vivo skin dosimetry.," Med. Phys. 32 (6), 1571-1578 (2005).
22. L. R. Coia, R. J. Myerson, and J. E. Tepper, " Late effects of radiation therapy on the gastrointestinal tract.," Int. J. Radiat. Oncol., Biol., Phys. 31 (5), 1213-1236 (1995).
23. R. Nath, L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, " Dosimetry of interstitial brachytherapy sources.," Med. Phys. 22 (2), 209-234 (1995).
24. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of AAPM Task Group No. 43 Report: A revised protocol for brachytherapy dose calculations.," Med. Phys. 22 (2), 209-234 (1995).
25. S. Raina, " Quantifying IOHDR brachtherapy underdosage resulting from an incomplete scatter environment.," Int. J. Radiat. Oncol., Biol., Phys. 61 (5), 1582-1586 (2005).
26. K. R. Russell and A. Ahnesjä, " Dose calculation in brachytherapy for a Ir192 source using a primary and scatter dose separation technique.," Phys. Med. Biol. 41, 1007-1024 (1996).
27. O. A. Elhanafy, " Comparison of two planning systems for HDR brachytherapy gynecological application.," J. Appl. Clin. Med. Phys. 2 (3), 114-120 (2001).
28. G. Anagnostopoulos, " The effect of patient inhomogeneities in oesophageal Ir-192 brachytherapy-Monte Carlo and analytical dosimetry study.," Phys. Med. Biol. 49, 2675-2685 (2004).
29. C. A. Mangold, " Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system.," Radiother. Oncol. 58, 43-51 (2001).
30. A. Rosenfeld, M. Carolan, and B. Allen, " MOSFET dosimeters: role of encapsulation in mixed gamma-neutron and megavoltage X-ray fields.," IEEE Trans. Electr. Insul. 42 (6), 1870-1877 (1995).
31. ICRP Publication 23, Anatomical, Physiological and Metabolic Characteristics (Pergamon, Oxford, 1975).
32. A. Holmes-Siedle, L. Adams, and G. Ensell, " MOS dosimeters: improvement of responsivity (dosimetres MOS amelioration de reponsivite).," IEEE Catalogue No. 91 THO400-2 (1991).
33. R. Ramaseshan, S. Russell, and P. O'Brien, " Clinical dosimetry using MOSFETs.," Int. J. Radiat. Oncol., Biol., Phys. 37 (4), 959-964 (1997).
34. S. Agostinelli, " Geant4a simulation toolkit.," Nucl. Instrum. Methods Phys. Res. A 506, 250-303 (2003).
35. P. Karaiskos, A. Angelopoulos, E. Pantelis, " Monte Carlo dosimetry of a new Ir192 pulsed dose rate brachytherapy source.," Med. Phys. 30 (1), 9-16 (2003).
36. J. Borg and D. W. O. Rogers, " Monte Carlo Calculations of Photon Spectra in Air from Ir192 Sources.," Institute for National Measurement Standards, National Research Council of Canada, 1999.
37. F. Ballester, " Monte Carlo dosimetric study of Best Industries and Alpha Omega Ir-192 brachytherapy seeds.," Med. Phys. 31 (12), 3298-3305 (2004).
38. C. S. Melhus and M. J. Rivard, " Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for Cs137, I125, Ir192, Pd103, and Yb169 sources.," Med. Phys. 33 (6), 1729-1737 (2006).
39. J. Ṕrez-Calatayud, D. Granero, and F. Ballester, " Phantom size in brachytherapy source dosimetric studies.," Med. Phys. 31, 2075-2081 (2004).
40. E. N. J. Th. van Lin, " Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate brachytherapy.," Int. J. Radiat. Oncol., Biol., Phys. 63 (2), 565-576 (2005).
41. A. Hille, " The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer: A prospective three-dimensional analysis.," Strahlenther. Onkol. 11, 709-716 (2005).
42. C. Fiorino, S. Gianolini, and A. E. Nahum, " A cylindrical model of the rectum: comparing dose volume, dose surface and dose wall histograms in the radio-therapy of prostate cancer.," Phys. Med. Biol. 48, 2603-2616 (2003).
43. O. J. Ott, " Accelerated partial breast irradiation with Iridium-192 multicatheter PDR/HDR brachytherapy.," Strahlenther. Onkol. 180 (10), 642-649 (2004).
44. F. Rachbauer, " High-dose-rate intraoperative brachytherapy (IOHDR) using flab technique in the treatment of soft tissue sarcomas.," Strahlenther. Onkol. 179 (7), 480-485 (2003).
45. R. A. Kinhikar, " Clinical application of a OneDose™ MOSFET for skin dose measurements during internal mammary chain irradiation with high dose rate brachytherapy in carcinoma of the breast.," Phys. Med. Biol. 51, N263-N268 (2006).
46. M. Pinkawa, " Influence of the initial rectal distension on posterior margins in primary and postoperative radiotherapy for prostate cancer.," Radiother. Oncol. 81, 284-290 (2006).